NewslettersMammary Cell NewsUncategorizedTargeted Nanoparticle for Co-Delivery of HER2 siRNA and a Taxane to Mirror the Standard Treatment of HER2+ Breast Cancer: Efficacy in Breast Tumor and Brain MetastasisBy Justin.choi - January 27, 202208A single therapeutic was developed based on trastuzumab-conjugated nanoparticles for co-delivering docetaxel and siRNA against HER2.[Small] 6445212 AAAAAAAA items 1 apa 0 default asc 1 171195 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract